Raúl Juntas‐Morales

Author

Raúl Juntas‐Morales

Also Known As

Juntas-Morales, Raul, Morales, R. J., Morales, R. Juntas, R. J. Morales, R. Juntas Morales, R. Juntas-Morales, R. Juntas‐Morales, RR Morales, Raoul Juntas-Morales, Raoul Morales

105

Publications

Citations

H-Index

Concepts

All Affiliations

Inserm Université de Montpellier Sorbonne Université Centre Hospitalier Universitaire de Montpellier Pitié-Salpêtrière Hospital

About

Raúl Juntas‐Morales is an author at Inserm specializing in medicine, neurology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	902
2	Engineering	2	2	58
3	Health Sciences	1	1	62
4	Public Health	1	1	18
5	Allergy	1	1	103

Raúl Juntas‐Morales

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study James F. Howard, Saskia Bresch, Angela Genge, The Lancet Neurology MedicineSurgeryClinical TrialsGeneralised Myasthenia Gravis	2023	213
Dietary BMAA Exposure in an Amyotrophic Lateral Sclerosis Cluster from Southern France Estelle Masseret, Sandra Anne Banack, Farid Boumédiène, PLoS ONE	2013	140
Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study Ines Dierick, Jonathan Baets, Joy Irobi, Brain	2007	122
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera Émilien Delmont, Alexandre Brodovitch, Ludivine Kouton, Journal of Neurology RheumatologyMedical DiagnosticsAllergyLupusDiagnostic Test	2020	103
FHL1 is a major host factor for chikungunya virus infection Laurent Meertens, Mohamed Lamine Hafirassou, Thérèse Couderc, Nature Chikungunya Virus InfectionMolecular VirologyPathogenesisViral PathogenesisVirology	2019	93
Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis Éric Thouvenot, Christophe Dematteï, Sylvain Lehmann, European Journal of Neurology	2019	91
Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis William Camu, Boris Tremblier, Carine Plassot, Neurobiology of Aging Amyotrophic Lateral SclerosisAlzheimer's DiseaseNeurological DisorderPrognostic FactorDegenerative Disease	2013	84
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial Vincent Meininger, Angela Genge, Leonard H van den Berg, The Lancet Neurology Amyotrophic Lateral SclerosisNeurological DisorderClinical NeurologyClinical TrialsPharmacotherapy	2017	82
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial William Camu, Marius Mickunas, Jean‐Luc Veyrune, EBioMedicine	2020	78
Axonal Neuropathies due to Mutations in Small Heat Shock Proteins: Clinical, Genetic, and Functional Insights into Novel Mutations Andoni Echaniz‐Laguna, Thomas Geuens, Philippe Petiot, Human Mutation GeneticsNeurochemical BiomarkersDisease Gene IdentificationHspb8 MutationsSynaptic Signaling	2017	69

Page 1